Drug abuse on the rise in Bengaluru, Smugglers start taking bus routes to deliver drugs

With a steady rise in the demand for drugs, smugglers start bus routes to safely deliver drugs to drug addicts. Recently, it is noted that racketeers choosing various transport modes and latest one is the easy bus routes to the Bengaluru city, mainly from the Mumbai.

In the last 15 days, Bengaluru unit of Narcotics Control Bureau (NCB) seized the large quantities of cocaine, ecstasy, and ketamine, all brought to the city by bus to Bengaluru.

57 years old Nigerian nabbed by the sleuths of the Bengaluru unit of Narcotics Control Bureau (NCB) from a semi-sleeper bus at Yeshwantpur. After the inspection of his bag, NCB found 13 top quality ecstasy tablets weighing a total of 4.2gm and worth Rs 3.2 lakh.

Related Posts

Lilly launches Mounjaro KwikPen in India

Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

  Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

Piramal Pharma Gets 3 USFDA Observations at US Facility

Piramal Pharma Gets 3 USFDA Observations at US Facility

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices